Jon assists technology, science based and other companies in all aspects of achieving commercial success. He represents companies and individuals around the world in joint ventures, technology transfer, mergers and acquisitions, venture capital, international law and securities law. Jon is a past Co-Chair of the Firm's Life Sciences Practice Group and Technology Transactions Practice Group.
Notable Experience
· Jon represents U.S. and non-U.S. biotech, pharmaceutical, research tool and medical device companies in transactions involving collaborations such as vaccines, drug delivery technologies, therapeutics, diagnostics, blood products, cardiology, antimicrobials, genomics and research tool technologies.
· Jon represents U.S. and non-U.S. biotech, pharmaceutical, research tool and medical device companies in venture financings, mergers and acquisitions.
· Jon represents software games and interactive media companies in a number of matters, including project development transactions, startups, and early and late stage financings and acquisitions. Jon has worked on such game titles as Empire Earth II, Empire Earth III, Bully, Star Trek Legacy, Dungeon Siege, Legends of Aranna, Expansion Set, Empire Earth II: the Art of Supremacy, Jane's Attack Squadron and Star Trek: Armada II.
· Jon is regularly involved in licensing research institution technologies to private companies for both companies and research institutions. For example, in 2004, represented a major university in a license to a major U.S. pharmaceutical company of a new drug treatment for hot flashes associated with menopause, as reported under "Big Deals" in IP Law and Business (January 2005).
· Jon represents clients in outsourcing, enterprise software, IT integration in all transactions including acquisitions and contracts.
· Jon represents specialized lenders in loan, project finance and other transactions in the food and agricultural industries.
· Jon has represents hotel developers in the project bid and development process including the negotiation of management agreements and financing.
Recent Speaking Engagements and Publications
Speaking Engagements
· Executive Coach, "Negotiating Term Sheets," TiE Start Up Leadership Program, December 5, 2011.
· Panelist, Concept Clinic, MIT Enterprise Forum December 1, 2011
· "Innovation and Entrepreneurship," panelist, Integrating Technology and Medicine for Healthier Tomorrow, IEEE EMBC Annual Meeting, Boston, Massachusetts, August 31, 2011.
· Semi-finalist Judge, 2nd Annual Cade Prize for Innovation, sponsored by the Cade Museum for Innovation, Gainesville, Florida, June 2011.
· Executive Coach, "Negotiating Term Sheet," TiE Start Up Leadership Program, February 7, 2011.
· Semi-finalist Judge, 1st Annual Cade Prize for Innovation, sponsored by the Cade Museum for Innovation, Gainesville, Florida, June 2010.
· "Drafting Representation and Warranty Provisions in the Agreement to Ensure the Protection of Both Parties," speaker, ACI's 3rd Annual Life Sciences Mergers & Acquisition Post Conference Workshop, New York, New York, March 13, 2009.
· "Structuring Collaborative Agreements that Won't Raise Antitrust Concerns," speaker, 4th Annual In-House Counsel Forum on Pharmaceutical Antitrust, National Harbor, Maryland, May 20-21, 2008.
· "Ethical, Practical, and Winning Strategies for Negotiating and Drafting Pharma/Biotech M&As," speaker, ACI's Life Sciences Mergers and Acquisitions Post Conference Master Class, New York, New York, March 14, 2008.
· "Top 10 Mistakes Entrepreneur's Make," speaker, The Brown Forum Enterprise, Providence, Rhode Island, January 24, 2008.
· "Moving Ahead: Identifying Current Deal Drivers and Trends Affecting Collaborations," speaker, ACI's Pharma and Biotech Collaborative Agreements 9th Advanced Forum On Structuring, Negotiating, and Managing Win-Win, New York, New York, November 13-14, 2007.
· "Nanobiotechnology," moderator, 9th Annual Mass Opportunities - A Biotechnology Conference, Boston, Massachusetts, November 8, 2007.
· "Managing Critical IP Protection and Commercialization Issues in Industry/Academia Collaborations," moderator, American Conference Institute's (ACI) Biotech and Pharma Public-Private Partnerships Conference, Washington, DC, October 25, 2007.
· "Partnering & Licensing," moderator, BioFlorida's 10th Annual Conference, Weston, Florida, October 15-17, 2007.
· "Licensing Transactions and Agreements," speaker, University of Massachusetts Dartmouth Advanced Technology & Manufacturing Center Entrepreneurs Brown Bag Speaker Series, Fall River, Massachusetts, May 15, 2007.
· "Assessing the Critical Role of License Type: Exclusivity, Non-Exclusivity, and Beyond," presenter, Pharma and Biotech Industry-Academia Tech Transfer - Bridge the Gap Between Discovery and Commercialization, New York, New York, February 6-7, 2007.
· "Negotiating Industry/University Collaborations: Ethical and Practical Strategies for Maximizing Return on Investment," panelist, American Conference Institute's Pharma and Biotech Collaborative Agreements, New York, New York, November 13-14, 2006.
· "Ensuring All Key IP Issues Are Addressed in Collaborative Agreements" and "Ethical and Practical Strategies for Maximizing ROI When Negotiating Industry/University Licenses," panelist, American Conference Institute's Negotiating & Drafting Pharma and Biotech Collaborative Agreements Conference, San Francisco, California, July 17 - 19, 2006.
· "Maximizing ROI from Industry/University Licenses- Practical Strategies", co-presenter, American Conference Institute's Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreement Conference, November 16, 2005.
· "Finding the Financing & Structuring the Deal", co-presenter, American Conference Institute's Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements Conference, November 14, 2005.
· "Practical Strategies for Negotiating and Structuring Academic-Industry Technology License Agreements," co-presenter, Boston Bar Association's Intellectual Property Law Committee Meeting, September 15, 2005.
· "Emerging Technology in New England and Canada," panelist, 6th Annual Trade, Technology and Investment Partnering Conference, New England Canada Business Council, Boston, Massachusetts, June 2005.
· "Practical and Ethical Strategies for Negotiating and Structuring Industry - University Licenses to Get the Best Return on Your Investment," panelist, American Conference Institute's Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements, Post Conference Workshop, San Francisco, California, March 2, 2005.
· "Structuring 'Win-Win' In-Licensing and Co-Development Collaborations with Universities," panelist, American Conference Institute's Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements, San Francisco, California, March 1, 2005.
· "Successful In-Licensing and Co-Development Collaborations with Universities," speaker, 8th Annual American Conference Institute's Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements, Philadelphia, Pennsylvania, November 2004.
· "Practical and Ethical Strategies for Negotiating and Structuring Industry-University Licenses To Get The Best Return On Your Investment," speaker, 8th Annual American Conference Institute's Pharma and Biotech In-Licensing, Co-Development, and Co-Promotion Agreements, Post Conference Workshop, Philadelphia, Pennsylvania, November 2004.
· "Doing Business With University Tech Transfer Offices: A Primer: Terms and Conditions of University Licensing Deals," speaker, Technology Transfer Conference, sponsored by Florida Research Council, May 2004.
· "University and Industry Collaboration on Licensing Transactions," speaker, BioTech 2004 Conference: Today's Bioscience Environment in South Florida, sponsored by Enterprise Development Corporation and Florida International University, March 2004.
· "Successful In-Licensing and Co-Development Collaborations with Universities," speaker, American Conference Institute's Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements, Philadelphia, Pennsylvania, November 2003.
· "Issues Unique to Industry/University Collaborations," speaker, Pharmaceutical/Biotech Collaborations: The Next Generation, New York, New York, May 2003.
· "Emerging Technologies in the Life Sciences Industry," speaker/moderator, New England Canada Business Council, 4th Annual Trade, Technology and Investment Partnering Conference, Boston, Massachusetts, April 2003.
· "Dealing with the Impact of a Merger on your Existing and Pending Collaborations," speaker, Consolidation in the Pharmaceutical Industry Conference, New York, New York, January 2003.
· "A Legal Primer on Starting Your Consulting Business," speaker, Optical Society of America, Northeast Section, 2002.
· "How to Protect the Respective IP Rights of Pharmaceutical and BioTech Collaborators," speaker, Pharmaceutical Biotech Collaborations and M&A Conference, New York, New York, 2002.
· "Guiding Inventions From Idea to Protected Property Right and to Market," speaker, BioEast Canada, 2001.
· "Investor Presentations," moderator, Canadian IT Financing Forum, 2001.
· "Legal Issue Series: Licensing Issues," speaker, Massachusetts Software Council, 1997.
Publications
· "Attorney's share entrepreneurs' IP mistakes," quoted, Mass High Tech, April 17, 2009.
· Jon was quoted in Myers, Natalie, "Some Make Mistakes Hurt More Than Others in Business," Providence Business News, February 4, 2008.
· Jon was quoted in Qualters, Sheri, "Cross-Licenses Grow; Legal Work Follows In-house Counsel", The National Law Journal, Vol. 29, No. 20, May 14, 2007.
· "Issues arising as focus sharpens on medical research," quoted, Boston Business Journal, March 11, 2005.
· "Reducing New Risks in Commercializing University Research," co-author, Intellectual Property Today, 2005.
· "Doing Biotech Deals: M & A and Partnerships," co-author, Books 24x7, 2005.
· "The Many Aspects of Technology Law," Inside the Minds: The Laws Behind Technology - Leading Lawyers On The Legal Aspects Of Patents, Software Licensing, Telecommunications & More, contributing author, Aspatore Books, 2004.
· "Morphing from Scientist to Industrialist in a Venture Financed Company," author, American Venture Magazine, 2002.
· "Negotiation American Style," author, The Practical Lawyer, 2002.
· "Going for Gold: Seeking Biotech Financing," quoted, Area Development Magazine, 2002.
· "For Buyouts, Mergers, Acquisitions, It's A Buyer's Market," quoted, Boston Business Journal, 2002.
· "So Sue Me: How to Avoid Litigation by Your Former Employer Against Your Start-Up," author, Boston Computer Society Magazine, 1993.
News & Publications
July 7, 2008, Edwards Angell Palmer & Dodge Recognized in the American Lawyer
April 10, 2008, EAPD Represents Takeda Pharmaceutical Company Limited in $8.8 Billion Acquisition of Millennium Pharmaceuticals
November 1, 2006, Edwards Angell Palmer & Dodge Attorneys Honored as Massachusetts Super Lawyers
March 11, 2005, Issues arising as focus sharpens on medical research
Boston Business Journal
12/1/2004, Reducing New Risks in Commercializing University Research
June 1, 2004, The New Massachusetts Business Corporation Act
Edwards & Angell, LLP
September 2002, Negotiation American Style
The Practical Lawyer
So Sue Me! How to avoid litigation by your former employer against your start up
Events
April 22, 2011, Tampa, FL, The National Academy of Inventors
March 24, 2009 - March 25, 2009, Philadelphia, PA, ACI's Advanced Forum on Strategies for Structuring, Negotiating and Managing Successful Drug Delivery Partnerships
March 13, 2009, New York, NY, ACI's 3rd Annual Life Sciences Mergers & Acquisition Post Conference Workshop
Drafting Representation and Warranty Provisions in the Agreement of Both Parties
May 20, 2008 - May 21, 2008, National Harbor, MD, 4th Annual In-House Counsel Forum on Pharmaceutical Antitrust
Minimizing Risk, Maximizing Patent Value, and Avoiding Anticompetitive Behavior
March 14, 2008, New York, NY, American Conference Institute's (ACI) Life Sciences Mergers and Acquisitions Post Conference Master Class
November 13, 2007 - November 14, 2007, New York, NY, ACI's Pharma and Biotech Collaborative Agreements 9th Advanced Forum On:
Structuring, Negotiating and Managing Win-Win
November 8, 2007, Boston, MA, 9th Annual Mass Opportunities - A Biotechnology Conference
October 25, 2007 - October 26, 2007, Washington, DC, Biotech and Pharma Public-Private Partnerships
October 15, 2007 - October 17, 2007, Weston, FL, BioFlorida's 10th Annual Conference
March 14, 2007, New York, NY, "Ethical, Practical, and Winning Strategies for Negotiating and Drafting Pharma/Biotech M&As" Post Conference Master Class
February 6, 2007 - February 7, 2007, New York, NY, Pharma and Biotech Industry-Academia Tech Transfer Conference
Bridge the Gap Between Discovery and Commercialization
November 13, 2006 - November 15, 2006 New York, NY, Pharma and Biotech Collaborative Agreements: Allocating Risk, Responsibilities & Rewards in In-Licensing, Co-Development & Co-Promotion Deals
July 17, 2006 - July 19, 2006, San Francisco, CA, Negotiating & Drafting BIOTECH/PHARMA Collaborative Agreements
Allocating Risk, Responsibilities & Rewards in In-Licensing, Co-Development & Co-Promotion Deals
February 5, 2006 - February 8, 2006, Carefree, AZ, Association of Corporate Patent Counsel Winter Meeting
July 12, 2005, Intellectual Property Legal Presentation - IP Driven Economic Growth
May 18, 2005, New England-Canada Business Council's (NECBC) 6th Annual Trade, Technology and Investment Partnering Conference
June 6, 2004 - June 9, 2004, BIO 2004
Edwards & Angell is a platinum sponsor of BIO 2004, International Biotechnology Convention and Exhibition held in San Francisco, CA on June 6-9, 2004.
May 18, 2004, First Annual Florida Research Consortium Conference
March 25, 2004, Third Annual BioTech Conference
Industries
· Technology
· Life Sciences
· Education
· Healthcare
· Food and Agriculture
· Cloud Computing & Managed IT Services
· Entertainment: Development, Production, Financing & Distribution
- Branded Entertainment
Memberships
· Boston Bar Association
· British-American Chamber of Commerce
· Licensing Executives Society
· Massachusetts Biotechnology Council
· Association of University Technology Managers